Skip to main content

InspireMD Inc

For the period ended Mar 31, 2024. Filed May 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

NSPR$0.78+9.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands)

20242023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss$(7,032)$(4,256)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation6955
Change in fair value of markable securities, net of interest received(218)-
Change in liability for employees rights upon retirement6636
Other financial expenses422
Change in operating right of use asset and operating leasing liability(25)(34)
Share-based compensation expenses2,618289
Loss on amounts funded in respect of employee rights upon retirement, net1423
Decrease in interest receivable on short term deposits-14
Changes in operating asset and liability items:
Decrease in prepaid expenses47261
Decrease (Increase) in trade receivables617(383)
Decrease (Increase) in other receivables165(97)
Increase in inventory(254)(76)
Decrease in trade payables(280)(52)
Decrease in other payables(855)(633)
Net cash used in operating activities(5,064)(4,831)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment(195)(25)
Investment in short-term bank deposits-(2,500)
Withdrawal from short-term bank deposits-7,000
Investments in marketable securities(1,960)-
Proceeds from matured marketable securities7,000-
Amounts funded in respect of employee rights upon retirement(28)(26)
Net cash provided by (used in) investing activities4,8174,449
CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash provided by (used in) financing activities--
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS(4)(22)
DECREASE IN CASH AND CASH EQUIVALENTS(251)(404)
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD9,6404,632
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD$9,389$4,228
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.